Insights into theese molecular mechanisms may facilitate the design of interventions to interfere with JAM-A–mediated extracellular binding or intracellular signaling, thereby offering novel approaches to mitigate its pro-atherogenic role in coronary artery disease. This evidence concerns the gene F11R and coronary artery disorder.